1-8 of 8
Rebecca E. Garris, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

Nicholas J Short, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Xuelin Huang, PhD, Nitin Jain, MD, Koji Sasaki, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Joseph David Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Yesid Alvarado, MD, Marina Y. Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, Musa Yilmaz, MD, Gautam Borthakur, MD, Jan A. Burger, MD PhD, Steven M. Kornblau, MD, William G. Wierda, MD PhD, Courtney D. DiNardo, MDMSc, Alessandra Ferrajoli, MD, Patrice Nasnas, MD, Jovitta Jacob, RN, Rebecca E. Garris, MSc, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 36.
https://doi.org/10.1182/blood-2018-99-114955
Published: 2018
Journal Articles

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) Vs. Standard Intensive Chemotherapy (hyper-CVAD) As Frontline Therapy for Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL): A Propensity Score Analysis

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Farhad Ravandi, MD, Maria Khouri, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Jovitta Jacob, RN, Rebecca E. Garris, MSc, Musa Yilmaz, MD, Philip A. Thompson, MBBS, Patrice Nasnas, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 34.
https://doi.org/10.1182/blood-2018-99-115271
Published: 2018
Journal Articles

Predictors of Outcomes in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia at First Relapse in the Era of Tyrosine Kinase Inhibitors

Iman Aboudalle, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Guillermo Garcia-Manero, MD, Rebecca E. Garris, MSc, Wei Qiao, PhD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Partow Kebriaei, MD, Tapan M. Kadia, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2659.
https://doi.org/10.1182/blood-2018-99-117579
Published: 2018
Journal Articles

Smoking Confers Poor Survival in Patients (Pts) with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with the Combination of Intensive Therapy with Tyrosine Kinase Inhibitor (TKI)

Elias J. Jabbour, MD, Koji Sasaki, MD, Farhad Ravandi, MD, Nicholas J Short, MD, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Zeev E. Estrov, MD, Rebecca E. Garris, MSc, Maria Khouri, Patrice Nasnas, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2664.
https://doi.org/10.1182/blood-2018-99-115325
Published: 2018
Journal Articles

A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Farhad Ravandi, MD, Alessandra Ferrajoli, MD, Heather M Schroeder, Maria Khouri, Guillermo Garcia-Manero, MD, Guillermo Montalban Bravo, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Marina Y. Konopleva, MD PhD, Koichi Takahashi, MD, Koji Sasaki, MD, Rebecca E. Garris, MSc, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 32.
https://doi.org/10.1182/blood-2018-99-117470
Published: 2018
Journal Articles

Sequential Combination of Low-Intensity Chemotherapy (Mini-hyper-CVD) Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed/Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL): A Phase 2 Trial

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Nicholas J Short, MD, Partow Kebriaei, MD, Xuelin Huang, PhD, Michael E. Rytting, MD, Nitin Jain, MD, Marina Y. Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Richard E Champlin, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Zeev E. Estrov, MD, Koichi Takahashi, MD, Morgan Mace, PharmD, Maria Khouri, Patrice Nasnas, MD, Jovitta Jacob, RN, Rebecca E. Garris, MSc, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 553.
https://doi.org/10.1182/blood-2018-99-115162
Published: 2018
Journal Articles

Ultrasensitive Duplex Sequencing of Pretreatment ABL1 Kinase Domain Mutations in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Nicholas J Short, MD, Hagop M. Kantarjian, MD, Koji Sasaki, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Marina Y. Konopleva, MD PhD, Ghayas C. Issa, MD, Rashmi Kanagal-Shamanna, MD, Steven M. Kornblau, MD, Guillermo Garcia-Manero, MD, Victor Rivera, PhD, Rebecca E. Garris, MSc, Jesse Salk, PhD, Justin Prichard, PhD, Jerald P. Radich, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1548.
https://doi.org/10.1182/blood-2018-99-115369
Published: 2018
Journal Articles

Dynamic Personalized Assessment of Outcome in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Koji Sasaki, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Nicholas J Short, MD, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Victoria Jeanis, RN, Joie Alvarez, RN, Maria Khouri, Patrice Nasnas, MD, Rebecca E. Garris, MSc, William G. Wierda, MD PhD, Philip A. Thompson, MBBS, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2695.
https://doi.org/10.1182/blood-2018-99-115212
Published: 2018